Finland· FI-REL-REL369

Norgesic

A orphenadrin, kombinationen product containing orphenadrine citrate + paracetamol, registered in Finland by Viatris Oy. The same ATC class is registered in 4 of our 19 countries.

ATC M03BC51

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNorgesicATCM03BC51REGISTER NO.FI-REL-REL369PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Orphenadrin, kombinationen is registered in 4 of 19 countries.

Countries holding a registration under ATC M03BC51 (orphenadrin, kombinationen), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Orphenadrin, kombinationen · ATC M03BC51

4 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Italyprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Orphenadrine citrate + Paracetamol
Manufacturer
Viatris Oy
Country
Finland (FI)
ATC code
M03BC51
ATC class
Orphenadrin, Kombinationen
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Orphenadrin, kombinationen in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All orphenadrin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Norgesic
  • Cyprus · Unigesic
  • Greece · Norgesic, Unigesic
  • Iceland · Norgesic
  • Malta · Norgesic, Unigesic
  • Sweden · Norgesic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd90dd4e-70b5-4040-85f8-669f6f5117cf
GET /v1/drugs/cd90dd4e-70b5-4040-85f8-669f6f5117cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "4",
  "form": "tabletti",
  "route": "Suun kautta",
  "ddd_unit": "ED",
  "strength": "35 mg / 450 mg",
  "atc_label": "orfenadriini, yhdistelmävalmisteet",
  "ma_number": "3382",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL369",
  "authorised_at": "1966-05-04"
}

See everything about orphenadrin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.